TNYA
HealthcareTenaya Therapeutics, Inc.
$0.81-0.05 (-5.57%)
Prev Close
$0.86
Open
$0.85
High
$0.85
Low
$0.81
Volume
1.97M
Market Cap
$153.5M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Tenaya Therapeutics, Inc. (TNYA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 15 insider sales totaling $5.07M. The most recent insider transaction was by COLUMN GROUP III GP, LP (10 percent owner), who sold $1.45M worth of shares on Feb 26, 2026. Tenaya Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $153.5M.
Buys (12M)
0
$0.00
Sells (12M)
15
$5.07M
Net Activity
Net Seller
$5.07M
Active Insiders
4
last 12 mo
TNYA Price Chart
TNYA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026↗ | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 2,520,985 | $0.58 | $1.45M | 1,862,540 |
| Feb 24, 2026↗ | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 829,734 | $0.61 | $504.8K | 2,374,050 |
| Feb 17, 2026↗ | Ali Faraz | director, officer: Chief Executive Officer | Sell | 29,724 | $0.64 | $19.1K | 452,415 |
| Feb 17, 2026↗ | Higa Tomohiro | SVP, Finance | Sell | 6,938 | $0.64 | $4.5K | 122,610 |
| Feb 17, 2026↗ | Tingley Whittemore | officer: Chief Medical Officer | Sell | 7,036 | $0.64 | $4.5K | 220,494 |
| Feb 12, 2026↗ | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 4,400,290 | $0.69 | $3.04M | 4,803,280 |
| Nov 17, 2025↗ | Ali Faraz | Chief Executive Officer | Sell | 3,126 | $1.33 | $4.2K | 299,666 |
| Nov 17, 2025↗ | Higa Tomohiro | SVP, Finance | Sell | 1,367 | $1.33 | $1.8K | 93,971 |
| Nov 17, 2025↗ | Tingley Whittemore | Chief Medical Officer | Sell | 2,877 | $1.33 | $3.8K | 169,926 |
| Aug 18, 2025↗ | Ali Faraz | Chief Executive Officer | Sell | 14,533 | $1.25 | $18.2K | 311,605 |
| Aug 18, 2025↗ | Higa Tomohiro | SVP, Finance | Sell | 2,962 | $1.25 | $3.7K | 97,777 |
| Aug 18, 2025↗ | Tingley Whittemore | Chief Medical Officer | Sell | 3,445 | $1.25 | $4.3K | 176,248 |
| May 16, 2025↗ | Ali Faraz | Chief Executive Officer | Sell | 3,189 | $0.44 | $1.4K | 317,325 |
| May 16, 2025↗ | Higa Tomohiro | SVP, Finance | Sell | 1,390 | $0.44 | $615.35 | 98,300 |
| May 16, 2025↗ | Tingley Whittemore | Chief Medical Officer | Sell | 2,937 | $0.44 | $1.3K | 171,856 |
| Mar 10, 2025↗ | Ali Faraz | Chief Executive Officer | Sell | 9,741 | $0.54 | $5.2K | 324,461 |
| Mar 10, 2025↗ | Higa Tomohiro | SVP, Finance | Sell | 2,482 | $0.54 | $1.3K | 101,155 |
| Mar 10, 2025↗ | Tingley Whittemore | Chief Medical Officer | Sell | 7,398 | $0.54 | $4.0K | 180,464 |
| Mar 7, 2025↗ | COLUMN GROUP III GP, LP | Buy | 35,714,284 | $0.70 | $25.00M | 49,313,600 | |
| Nov 18, 2024↗ | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,258 | $2.12 | $4.8K | 60,983 |
| Aug 19, 2024↗ | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,363 | $2.89 | $6.8K | 64,702 |
| Aug 16, 2024↗ | Ali Faraz | Chief Executive Officer | Sell | 9,748 | $2.89 | $28.2K | 192,277 |
| Aug 16, 2024↗ | Tingley Whittemore | Chief Medical Officer | Sell | 7,428 | $2.89 | $21.5K | 108,731 |
| Mar 6, 2024↗ | Hoey Timothy | Chief Scientific Officer | Sell | 3,300 | $7.00 | $23.1K | 245,346 |
| Feb 21, 2024↗ | Hoey Timothy | Chief Scientific Officer | Sell | 6,569 | $5.34 | $35.0K | 236,346 |
| Feb 16, 2024↗ | Ali Faraz | Chief Executive Officer | Sell | 6,358 | $5.86 | $37.3K | 113,079 |
| Feb 16, 2024↗ | Hoey Timothy | Chief Scientific Officer | Sell | 4,681 | $5.86 | $27.4K | 242,715 |
| Feb 16, 2024↗ | PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sell | 5,201 | $5.86 | $30.5K | 60,755 |
| Feb 16, 2024↗ | Tingley Whittemore | Chief Medical Officer | Sell | 6,500 | $5.86 | $38.1K | 73,534 |
| Feb 14, 2024↗ | COLUMN GROUP III GP, LP | Buy | 2,222,222 | $4.50 | $10.00M | 13,599,300 | |
| Aug 29, 2023↗ | Hoey Timothy | Chief Scientific Officer | Sell | 7,243 | $4.26 | $30.9K | 247,396 |
| Aug 18, 2023↗ | Ali Faraz | Chief Executive Officer | Sell | 5,563 | $3.81 | $21.2K | 119,437 |
| Aug 18, 2023↗ | Hoey Timothy | Chief Scientific Officer | Sell | 4,007 | $3.81 | $15.3K | 254,639 |
| Aug 18, 2023↗ | PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sell | 4,452 | $3.81 | $17.0K | 64,542 |
| Aug 18, 2023↗ | Tingley Whittemore | Chief Medical Officer | Sell | 5,563 | $3.81 | $21.2K | 76,437 |
| Mar 14, 2023↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 6,779 | $2.60 | $17.6K | 11,377,100 |
| Feb 10, 2023↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 1,500,000 | $2.60 | $3.90M | 11,370,300 |
| Jan 23, 2023↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 69,739 | $2.50 | $174.2K | 9,870,270 |
| Jan 19, 2023↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 185,151 | $2.51 | $464.8K | 9,800,540 |
| Dec 9, 2022↗ | Srivastava Deepak | Director | Buy | 230,769 | $2.60 | $600.0K | 372,435 |
| Nov 25, 2022↗ | Casdin Eli | Director | Buy | 2,492,042 | $2.60 | $6.48M | 6,078,860 |
| Nov 23, 2022↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 9,615,384 | $2.60 | $25.00M | 9,615,380 |
| Apr 28, 2022↗ | Hoey Timothy | Chief Scientific Officer | Sell | 1,353 | $10.13 | $13.7K | 198,646 |
| Aug 4, 2021↗ | Casdin Partners Master Fund, L.P. | 10% Owner | Buy | 850,000 | $15.00 | $12.75M | 3,224,850 |
TNYA Insider Buying Activity
The following table shows recent insider purchases of Tenaya Therapeutics, Inc. (TNYA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 7, 2025↗ | COLUMN GROUP III GP, LP | Buy | 35,714,284 | $0.70 | $25.00M | 49,313,600 | |
| Feb 14, 2024↗ | COLUMN GROUP III GP, LP | Buy | 2,222,222 | $4.50 | $10.00M | 13,599,300 | |
| Mar 14, 2023↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 6,779 | $2.60 | $17.6K | 11,377,100 |
| Feb 10, 2023↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 1,500,000 | $2.60 | $3.90M | 11,370,300 |
| Jan 23, 2023↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 69,739 | $2.50 | $174.2K | 9,870,270 |
| Jan 19, 2023↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 185,151 | $2.51 | $464.8K | 9,800,540 |
| Dec 9, 2022↗ | Srivastava Deepak | Director | Buy | 230,769 | $2.60 | $600.0K | 372,435 |
| Nov 25, 2022↗ | Casdin Eli | Director | Buy | 2,492,042 | $2.60 | $6.48M | 6,078,860 |
| Nov 23, 2022↗ | COLUMN GROUP III GP, LP | 10% Owner | Buy | 9,615,384 | $2.60 | $25.00M | 9,615,380 |
| Aug 4, 2021↗ | Casdin Partners Master Fund, L.P. | 10% Owner | Buy | 850,000 | $15.00 | $12.75M | 3,224,850 |
TNYA Insider Selling Activity
The following table shows recent insider sales of Tenaya Therapeutics, Inc. (TNYA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026↗ | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 2,520,985 | $0.58 | $1.45M | 1,862,540 |
| Feb 24, 2026↗ | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 829,734 | $0.61 | $504.8K | 2,374,050 |
| Feb 17, 2026↗ | Ali Faraz | director, officer: Chief Executive Officer | Sell | 29,724 | $0.64 | $19.1K | 452,415 |
| Feb 17, 2026↗ | Higa Tomohiro | SVP, Finance | Sell | 6,938 | $0.64 | $4.5K | 122,610 |
| Feb 17, 2026↗ | Tingley Whittemore | officer: Chief Medical Officer | Sell | 7,036 | $0.64 | $4.5K | 220,494 |
| Feb 12, 2026↗ | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 4,400,290 | $0.69 | $3.04M | 4,803,280 |
| Nov 17, 2025↗ | Ali Faraz | Chief Executive Officer | Sell | 3,126 | $1.33 | $4.2K | 299,666 |
| Nov 17, 2025↗ | Higa Tomohiro | SVP, Finance | Sell | 1,367 | $1.33 | $1.8K | 93,971 |
| Nov 17, 2025↗ | Tingley Whittemore | Chief Medical Officer | Sell | 2,877 | $1.33 | $3.8K | 169,926 |
| Aug 18, 2025↗ | Ali Faraz | Chief Executive Officer | Sell | 14,533 | $1.25 | $18.2K | 311,605 |
| Aug 18, 2025↗ | Higa Tomohiro | SVP, Finance | Sell | 2,962 | $1.25 | $3.7K | 97,777 |
| Aug 18, 2025↗ | Tingley Whittemore | Chief Medical Officer | Sell | 3,445 | $1.25 | $4.3K | 176,248 |
| May 16, 2025↗ | Ali Faraz | Chief Executive Officer | Sell | 3,189 | $0.44 | $1.4K | 317,325 |
| May 16, 2025↗ | Higa Tomohiro | SVP, Finance | Sell | 1,390 | $0.44 | $615.35 | 98,300 |
| May 16, 2025↗ | Tingley Whittemore | Chief Medical Officer | Sell | 2,937 | $0.44 | $1.3K | 171,856 |
| Mar 10, 2025↗ | Ali Faraz | Chief Executive Officer | Sell | 9,741 | $0.54 | $5.2K | 324,461 |
| Mar 10, 2025↗ | Higa Tomohiro | SVP, Finance | Sell | 2,482 | $0.54 | $1.3K | 101,155 |
| Mar 10, 2025↗ | Tingley Whittemore | Chief Medical Officer | Sell | 7,398 | $0.54 | $4.0K | 180,464 |
| Nov 18, 2024↗ | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,258 | $2.12 | $4.8K | 60,983 |
| Aug 19, 2024↗ | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,363 | $2.89 | $6.8K | 64,702 |
| Aug 16, 2024↗ | Ali Faraz | Chief Executive Officer | Sell | 9,748 | $2.89 | $28.2K | 192,277 |
| Aug 16, 2024↗ | Tingley Whittemore | Chief Medical Officer | Sell | 7,428 | $2.89 | $21.5K | 108,731 |
| Mar 6, 2024↗ | Hoey Timothy | Chief Scientific Officer | Sell | 3,300 | $7.00 | $23.1K | 245,346 |
| Feb 21, 2024↗ | Hoey Timothy | Chief Scientific Officer | Sell | 6,569 | $5.34 | $35.0K | 236,346 |
| Feb 16, 2024↗ | Ali Faraz | Chief Executive Officer | Sell | 6,358 | $5.86 | $37.3K | 113,079 |
| Feb 16, 2024↗ | Hoey Timothy | Chief Scientific Officer | Sell | 4,681 | $5.86 | $27.4K | 242,715 |
| Feb 16, 2024↗ | PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sell | 5,201 | $5.86 | $30.5K | 60,755 |
| Feb 16, 2024↗ | Tingley Whittemore | Chief Medical Officer | Sell | 6,500 | $5.86 | $38.1K | 73,534 |
| Aug 29, 2023↗ | Hoey Timothy | Chief Scientific Officer | Sell | 7,243 | $4.26 | $30.9K | 247,396 |
| Aug 18, 2023↗ | Ali Faraz | Chief Executive Officer | Sell | 5,563 | $3.81 | $21.2K | 119,437 |
| Aug 18, 2023↗ | Hoey Timothy | Chief Scientific Officer | Sell | 4,007 | $3.81 | $15.3K | 254,639 |
| Aug 18, 2023↗ | PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sell | 4,452 | $3.81 | $17.0K | 64,542 |
| Aug 18, 2023↗ | Tingley Whittemore | Chief Medical Officer | Sell | 5,563 | $3.81 | $21.2K | 76,437 |
| Apr 28, 2022↗ | Hoey Timothy | Chief Scientific Officer | Sell | 1,353 | $10.13 | $13.7K | 198,646 |
TNYA Insiders
Similar Stocks to TNYA
VRTX
Vertex Pharmaceuticals Incorporated
$452.29-2.20%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$745.34-1.66%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$317.24-0.96%
$42.07B
INSM
Insmed Incorporated
$143.85-0.06%
$30.07B
UTHR
United Therapeutics Corporation
$531.23-1.63%
$23.50B
MRNA
Moderna, Inc.
$52.27-3.15%
$20.76B
ROIV
Roivant Sciences Ltd.
$27.86-1.55%
$20.08B
RPRX
Royalty Pharma plc
$45.94-0.36%
$19.56B